Tetrylammonium

Tetrylammonium

SCHEMBL1996794

CC[N+](CC)(CC)CC.CC[N+](CC)(CC)CC.CC[N+](CC)(CC)CC.CC[N+](CC)(CC)CC.CC[N+](CC)(CC)CC.CC[N+](CC)(CC)CC.CC[N+](CC)(CC)CC.CC[N+](CC)(CC)CC.N#CB([O-])[O-].N#CB([O-])[O-].N#CB([O-])[O-].N#CB([O-])[O-]

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.47
NFKB1 P19838 1/20 0.47
KCNA1 Q09470 1/20 0.47
KDM4E B2RXH2 1/20 0.44
PMP22 Q01453 1/20 0.44
ATM Q13315 1/20 0.44
ALDH1A1 P00352 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tetrylammonium SCHEMBL899273 0.83 TSHR (0.42) TSHRNFKB1KCNA1KDM4EPMP22
SCHEMBL15212489 0.82 ALDH1A1 (0.30) ALDH1A1
Tetrylammonium SCHEMBL8777992 0.81 TSHR (0.61) TSHRNFKB1KCNA1KDM4EPMP22
SCHEMBL1994142 0.80
SCHEMBL15212237 0.80
Tetrylammonium SCHEMBL10770115 0.78 TSHR (0.42) TSHRNFKB1KCNA1KDM4EPMP22
Tetrapropylammonium SCHEMBL1467525 0.78 SLC22A1 (0.53) TSHRALDH1A1
Tetrylammonium SCHEMBL1006716 0.78 TSHR (0.57) TSHRNFKB1KCNA1KDM4EPMP22
SCHEMBL18604116 0.78 DNM1 (0.64) TSHRALDH1A1
Tetrylammonium SCHEMBL4340516 0.77 TSHR (0.67) TSHRNFKB1KCNA1KDM4EPMP22

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260139573-A1 POWER SYSTEM FOR DOWNHOLE TOOLSTRING FASTCAP ULTRACAPACITORS LLC (US) 2026-05-21 US disclosed
US-12529291-B2 Power system for downhole toolstring FASTCAP ULTRACAPACITORS LLC (US) 2026-01-20 US disclosed
EP-3251133-B1 WIDE OPERATING TEMPERATURE RANGE (0° TO 275°C) ULTRACAPACITOR FASTCAP ULTRACAPACITORS LLC (US) 2025-12-24 EP disclosed
EP-4661040-A2 WIDE TEMPERATURE RANGE ULTRACAPACITOR FastCAP Ultracapacitors LLC (US) 2025-12-10 EP disclosed
US-20250062080-A1 ADVANCED ELECTROLYTE SYSTEMS AND THEIR USE IN ENERGY STORAGE DEVICES FASTCAP SYSTEMS CORPORATION 2025-02-20 US disclosed
US-12165806-B2 Advanced electrolyte systems and their use in energy storage devices FASTCAP SYSTEMS CORPORATION (US) 2024-12-10 US disclosed
EP-4428886-A2 ULTRACAPACITORS WITH HIGH FREQUENCY RESPONSE FastCAP Systems Corporation (US) 2024-09-11 EP disclosed
EP-3084785-B1 ULTRACAPACITORS WITH HIGH FREQUENCY RESPONSE FASTCAP SYSTEMS CORP (US) 2024-07-24 EP disclosed
US-20240006130-A1 ADVANCED ELECTROLYTE SYSTEMS AND THEIR USE IN ENERGY STORAGE DEVICES WINDSAIL CAPITAL FUND, L.P. 2024-01-04 US disclosed
US-20230374888-A1 POWER SYSTEM FOR DOWNHOLE TOOLSTRING WINDSAIL CAPITAL FUND, L.P. 2023-11-23 US disclosed
US-20140265565-A1 MODULAR SIGNAL INTERFACE DEVICES AND RELATED DOWNHOLE POWER AND DATA SYSTEMS FASTCAP SYSTEMS CORPORATION (US) 2014-09-18 US disclosed
US-20140042988-A1 ADVANCED ELECTROLYTE SYSTEMS AND THEIR USE IN ENERGY STORAGE DEVICES FASTCAP SYSTEMS CORPORATION (US) 2014-02-13 US disclosed
WO-2013126915-A1 ADVANCED ELECTROLYTE SYSTEMS AND THEIR USE IN ENERGY STORAGE DEVICES FASTCAP SYSTEMS CORPORATION (US) 2013-08-29 WO disclosed
US-20110150736-A1 IONIC COMPOUND, METHOD FOR PRODUCING THE SAME, AND ION-CONDUCTIVE MATERIAL COMPRISING THE SAME NIPPON SHOKUBAI CO., LTD. (JP) 2011-06-23 US disclosed
EP-2327707-A1 IONIC COMPOUND, PROCESS FOR PRODUCING SAME, AND ION-CONDUCTIVE MATERIAL COMPRISING SAME Nippon Shokubai Co., Ltd. (JP) 2011-06-01 EP disclosed
EP-1726594-A1 Salts comprising cynoborate anions Merck Patent GmbH (DE) 2006-11-29 EP disclosed
EP-1726593-A1 Salts comprising cyanoborate anions Merck Patent GmbH (DE) 2006-11-29 EP disclosed
EP-1592696-B1 SALTS COMPRISING CYANOBORATE ANIONS MERCK PATENT GMBH (DE) 2006-09-27 EP disclosed
EP-1592696-A1 SALTS COMPRISING CYANOBORATE ANIONS MERCK PATENT GmbH (DE) 2005-11-09 EP disclosed
WO-2004072089-A1 SALTS COMPRISING CYANOBORATE ANIONS MERCK PATENT GMBH (DE) 2004-08-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110150736-A1 IONIC COMPOUND, METHOD FOR PRODUCING THE SAME, AND ION-CONDUCTIVE MATERIAL COMPRISING THE SAME KCNB1, KCNB2, KCNMB1 TSHR 2693/4885NFKB1 678/4885KCNA1 16/4885
US-12529291-B2 Power system for downhole toolstring ERCC1, MRE11, SCN2B TSHR 842/4885NFKB1 3732/4885KCNA1 1344/4885
US-20260139573-A1 POWER SYSTEM FOR DOWNHOLE TOOLSTRING PARP2, PRKAG2, PRKAA2 TSHR 3310/4885NFKB1 3617/4885KCNA1 4693/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.